CHM
Click for more information
10.5% 2.1¢ chimeric therapeutics limited

Ann: Cell therapy industry leader appointed Chief Medical Officer, page-4

  1. QiQi
    1,070 Posts.
    lightbulb Created with Sketch. 546
    clock Created with Sketch.
    25/07/22
    09:33
    Post #: 62704760
    It always makes life easier for an investor of a speculative stock, when the team involved (new and old) come from these companies:

    - Juno Therapeutics | $9B |
    - Kite Pharma | $11.9B |
    - Celgene | $95B |

    All with proven track records, from the best of the best in the world of cell therapy.
    CHM Price at posting: 12.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 17  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

LKE Lake Resources implies news article on job cuts made up; non-core sales "not material" and no rule 15.7 breach
right-arrow Created with Sketch.
MM1 Geochemical work at Newington picks up gold and copper anomalies for Midas
right-arrow Created with Sketch.
FHE Frontier Energy lines up $215 million debt financing from Mike Cannon-Brookes-backed Infradebt
right-arrow Created with Sketch.
NEWS Warren Tredrea’s weekly sports business wrap: the latest on business in sport
right-arrow Created with Sketch.
1CG One Click Group surpasses $3M in revenue YTD with 40% growth
right-arrow Created with Sketch.
NEWS Real estate dynamics & changes raise investor doubt
right-arrow Created with Sketch.
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
(20min delay)
Last
2.1¢ 		Change
0.002(10.5%) 		Mkt cap ! $18.39M
Open High Low Value Volume
2.0¢ 2.1¢ 2.0¢ $30.13K 1.439M

Buyers (Bids)

No. Vol. Price($)
6 623541 2.0¢
 

Sellers (Offers)

Price($) Vol. No.
2.1¢ 423206 1
View Market Depth
Last trade - 15.53pm 25/07/2024 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.